Secretory non-pancreatic phospholipase A2: Influence on lipoprotein metabolism

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2232-2239

  De Beer, Frederick C ^a   De Beer, Maria C ^b   Van Der Westhuyzen, Deneys R ^a   Castellani, Lawrence W ^c   Lusis, Aldons J ^c   Swanson, Mark E ^d   Grass, David S ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Chrysalis DNX Transgenic Sciences   (United States)

Author keywords

Group 11 sPLA2; HDL; Inflammation; LDL; Transgenic mice

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; ENZYME RELEASE; INFLAMMATION; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS B; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MICE; MICE, TRANSGENIC; PHOSPHOLIPASES A; PROTEIN BINDING;

EID: 0030666857     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. 2: role in physiologic and inflammatory processes. J. Lipid Mediat. 8: 161-167.
2. 2. Biochim. Biophys. Acta. 1170: 217-231.
3. 2. J. Biol. Chem. 269: 13057-13060.
4. 2 genes in the tissues of endotoxin shocked rats and its suppression of glucocorticoid. FEBS Lett. 273: 23-26.
5. 2 purified from an inflammatory exudate. Biochemistry. 25: 8381-8385.
6. 2. J. Biol. Chem. 264: 5768-5775.
7. 2 S-1. J. Biol. Chem. 263: 5732-5738.
8. 2. J. Biol. Chem. 264: 10008-10014.
9. 2 in inflammatory diseases. Clin. Chem. 39: 2453-2459.
10. 2. Rev. Physiol. Biochem. Pharmacol. 91: 192-203.
11. 2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity. J. Biol. Chem. 271: 26307-26314.
12. 2. Kinetic characterization using the monomolecular film technique. Eur. J. Biochem. 204: 793-797.
13. Bausserman, L. L., D. N. Bernier, K. P. McAdam, and P. N. Herbert. 1988. Serum amyloid A and high density lipoproteins during the acute phase response. Eur. J. Clin. Invest. 18: 619-626.
14. Rossner, S. 1978. Further studies on serum lipoproteins in connective tissue diseases. Atherosclerosis. 31: 93-99.
15. 2 correlates with disease activity in rheumatoid arthritis. J. Rheumatol. 15: 1351-1355.
16. Wolfe, F., D. M. Mitchell, J. T. Sibley, J. F. Fries, D. A. Bloch, C. A. Williams, P. W. Spitz, M. Hager, S. M. Kleinheksel, and M. A. Cathey. 1994. The mortality of rheumatoid arthritis. Arthritis Rheum. 37: 481-494.
17. Liao, F., A. Andalibi, F. C. de Beer, A. M. Fogelman, and A. J. Lusis. 1993. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91: 2572-2579.
18. 2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediat. 8: 1-30.
19. 2 in human atherosclerotic plaques. Atherosclerosis. 118: 173-181.
20. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97: 2233-2241.
21. Linton, M. F., R. V. Farese, Jr., G. Chiesa, D. S. Grass, P. Chin, R. E. Hammer, H. H. Hobbs, and S. G. Young. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B-100 and lipoprotein [a]. J. Clin. Invest. 92: 3029-3037.
22. 2. J. Biol. Chem. 264: 5768-5775.
23. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
24. De Beer, M. C., M. S. Kindy, W. S. Lane, and F. C. de Beer. 1994. Mouse serum amyloid A protein (SAA5): structure and expression. J. Biol. Chem. 269: 4661-4667.
25. Hendrick, C. C., L. W. Castellani, C. H. Warden, D. L. Puppione, and A. J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268: 20676-20682.
26. Grant, K. I., L. A. F. Casciola, G. A. Coetzee, G. A. Sanan, W. Gevers, and D. R. van der Westhuyzen. 1990. Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and accelerates receptor degradation. J. Biol. Chem. 265: 4041-4047.
27. Basu, S. K., J. L. Goldstein, R. G. W. Anderson, and M. S. Brown. 1981. Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts. Cell. 24: 493-502.
28. Silverman, D. I., G. S. Ginsberg, and R. C. Pasternak. 1993. High density lipoprotein subfractions. Am. J. Med. 94: 636-645.
29. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 3000-3004.
30. De Beer, F. C., M. L. Baltz, E. A. Munn, A. Feinstein, J. Taylor, C. Bruton, J. R. Clamp, and M. B. Pepys. 1982. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunol. Methods. 45: 55-70.
31. Godenir, N. L., M. S. Jeenah, G. A. Coetzee, D. R. van der Westhuyzen, A. F. Strachan, and F. C. de Beer. 1985. Standardization of the quantitation of serum amyloid A protein (SAA) in human serum. J. Immunol. Methods. 83: 217-225.
32. Fidge, N., P. Nestel, T. Ishikawa, M. Reardon, and T. Billington. 1980. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism. 29: 643-653.
33. Schaefer, E. J., L. A. Zech, L. L. Jenkins, T. J. Bronzert, K. A. Rubalcaha, F. T. Lindgren, R. L. Aamodt, and H. B. Brewer, Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res. 23: 850-862.
34. Gylling, H., G. L. Vega, and S. M. Grundy. 1992. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J. Lipid Res. 33: 1527-1539.
35. Rader, D. J., K. Ikewaki, N. Duverger, H. Schmidt, H. Pritchard, J. Frohlich, M. Clerc, M. F. Dumon, T. Fairwell, L. Zech, S. Santamarino-Fojo, and H. B. Brewer, Jr. 1994. Markedly accelerated catabolism of apolipoprotein A-II (apoA-II) and high density lipoproteins containing apoA-II in classic LCAT deficiency and fish-eye disease. J. Clin. Invest. 93: 321-330.
36. Ikewaki, K., D. J. Rader, T. Sakamoto, M. Nishiwaki, N. Wakimoto, J. Schaefer, T. Ishikawa, T. Fairwell, L. Zech, H. Nakamura, M. Nagano, and H. B. Brewer, Jr. 1993. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J. Clin. Invest. 92: 1650-1658.
37. Bamberger, M., J. M. Glick, and G. H. Rothblat, 1983. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J. Lipid Res. 24: 869-876.
38. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3: density, size and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
39. Bamberger, M., S. Lund-Katz, M. C. Phillips, and G. H. Rothblat. 1985. Mechanism of the hepatic lipase-induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry. 24: 3693-3701.
40. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identinfication of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science. 271: 518-520.
41. Rigotti, A., S. L. Acton, and M. Krieger. 1995. The class B scavenger receptors SR-B1 and CD-36 are receptors for anionic phospholipids. J. Biol. Chem. 270: 16221-16224.
42. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 261: 171-174.
43. 2. Biochem. J. 309: 461-464.
44. Kisilevsky, R., and L. Subrahmanyan. 1992. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab. Invest. 66: 778-785.
45. Shephard, E. G., F. C. de Beer, M. C. de Beer, M. S. Jeenah, G. A. Coetzee, and D. R. van der Westhuyzen. 1987. Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. Biochem. J. 248: 919-926.